Photodynamic Drug Delivery for Cancer Therapy: A New Approach in Liposomes for Light-Controlled Release

Strategic Insights -

A team of researchers from the University Grenoble-Alpes has made significant advancements in the field of biotechnology, particularly in cancer gene therapy. Their study, published in the European Journal of Pharmaceutical Sciences, explores the potential of photodynamic drug delivery systems in cancer treatment. The researchers propose a novel approach using lipid nanoformulations that can be controlled by light to release therapeutic agents. This innovation aims to enhance the efficacy of cancer therapy while minimizing side effects.

Key Takeaways:

  • The researchers identified key design considerations for lipid nanoformulations in photodynamic drug delivery, including susceptibility to photochemical redox reactions, ability to induce lysosomal permeabilization, and microenvironmental priming that enhances tumor permeability.
  • The selection of photosensitizing agents is crucial, as they should ideally absorb light at 650nm and exhibit limited leaching.
  • The choice of photosensitizing agent and pharmaceutical cargoes determines the drug loading approach and release detection methods.
  • Nuclear magnetic resonance (NMR) spectroscopy is highlighted as a promising non-destructive quantification method for encapsulated and released pharmaceutical cargoes.
  • A multi-model approach is recommended to evaluate novel photodynamic drug delivery systems and consider the corollary effects on cancer cells and the microenvironment.

Statistics:

  • The study proposes a novel approach to cancer therapy using photodynamic drug delivery systems.
  • The lipid nanoformulations designed in this study are expected to improve the efficacy of cancer treatment.
  • The photodynamic therapy is estimated to enhance the release efficiency of therapeutic agents.
  • The use of NMR spectroscopy can quantify encapsulated and released pharmaceutical cargoes without complex sample preparation.

Sources:

  • European Journal of Pharmaceutical Sciences, 2025:107221. (Elsevier - www.elsevier.com; European Journal of Pharmaceutical Sciences - www.journals.elsevier.com/european-journal-of-pharmaceutical-sciences/)
  • Ahmed Gamal Ali Abdelhamid, Institute for Advanced Biosciences, University Grenoble-Alpes, INSERM U1209, CNRS UMR5309, Allee des Alpes, 38700 La Tronche, France.
  • Tristan Le Clainche, Nazareth Milagros Carigga Gutierrez, Marie-Anne Jourdain, Sofia Leo, Lucie Sancey, Amandine Hurbin, Jean-Luc Coll, Benedicte Elena-Herrmann, and Mans Broekgaarden.